Schedule 13G ownership disclosure
MILESTONE PHARMACEUTICALS IN
Security class unavailable · CUSIP: 59935V107
Event date: 2022-10-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001319244-22-000176
- Form type
- SC 13G
- Filer
- INTEGRATED CORE STRATEGIES (US) LLC
- CIK
- CIK 1319244
- Filed
- Oct 31, 2022
- Reporting period
- Oct 25, 2022
- Description
- Schedule 13G beneficial ownership